Deals
Keryx Biopharmaceuticals Raises $125M From Baupost Group Securities
|
Keryx Biopharmaceuticals (NASDAQ CM:KERX) announced that it has raised $125,000,000 in a Convertible Senior Notes transaction.
Growth Capitalist (https://growthcapitalist.com/category/deals/page/115/)
Recent growth capital transactions by pre-IPO private and public emerging growth companies
Keryx Biopharmaceuticals (NASDAQ CM:KERX) announced that it has raised $125,000,000 in a Convertible Senior Notes transaction.
Affimed N.V. (NASDAQ GM:AFMD) announced that it has raised $21,800,000 in a Common Stock transaction.
Rosetta Genomics Limited (NASDAQ CM:ROSG) announced that it has raised $7,999,999 in a Units (Common Stock + Warrants) transaction.
Cachet Financial Solutions (OTC BB:CAFN) announced that it has secured up to $10,000,000 in a Structured Equity Line transaction.